State AI Laws, One Brand Story: Keeping Pharma Marketing Coherent Across 2026’s Patchwork Rules
Imagine launching a national pharma campaign—only to find half your creative needs rewriting because a few states just passed new AI disclosure laws. Welcome...
Webinar Fatigue Is Real: Why Modular HCP Education Is Pharma’s Next Big Play
Healthcare professionals (HCPs) are overwhelmed. Back-to-back webinars, dense slides, and rigid Continuing Medical Education (CME) modules make learning feel like a burden instead of...
Insurance as Audience: How to Market to Payers Without Saying Their Name
Marketing to healthcare payers is evolving fast. Payers are consuming brand content—directly and indirectly—through omnichannel and disease-state messaging. This article explores how pharma marketers...
The Rise of the Digital Prescriber: How AI Tools Are Rewiring Pharma Influence
What happens when the power to influence prescribing decisions shifts from human reps to intelligent software? Pharmaceutical marketers are facing that very reality as...
When the Drug Is Also a Device: A Marketing Playbook for Hybrid Therapeutics
Imagine launching a treatment that’s not just a medication—but also a digital tool, a wearable device, or an automated injector. That’s the reality with...
From ESG to RFP Wins: How Sustainability Is Reshaping Pharma Marketing
In today’s healthcare landscape, weaving ESG principles into pharma marketing is no longer optional. As payers, procurement teams, and institutional buyers increasingly evaluate pharmaceutical...
Hyperlocal but Compliant: How to Target by Zip Code Without Crossing the Line
What if you could reach patients more effectively by simply understanding their zip code—but without ever compromising privacy? Zip-code-level targeting is one of pharma...
Beyond the Static MOA: How to Design AI‑Optimized Explainer Videos for Pharma
In a world where artificial intelligence shapes how content is discovered and recommended, the traditional static mechanism of action (MOA) video is quickly becoming...
FTC Pharma Promotion Rules in 2026: What Now Counts as “Advertising”?
In 2026, the landscape of pharmaceutical marketing is undergoing one of the most significant shifts in decades. The Federal Trade Commission’s (FTC) evolving interpretation...
The Invisible EHR: Why Clinical UX Is the Silent Driver of Pharma Engagement
Electronic Health Records (EHRs) are the backbone of modern clinical workflows, yet the user experience within EHR platforms often remains an overlooked factor in...
